|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,390 JPY | -0.79% |
|
-0.28% | -11.64% |
| Apr. 12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
| Apr. 12 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
COSMOS Pharmaceutical Corporation reported earnings results for the first quarter ended August 31, 2023. For the first quarter, the company reported sales was JPY 241,653 million compared to JPY 206,122 million a year ago. Net income was JPY 6,508 million compared to JPY 6,481 million a year ago.
Basic earnings per share from continuing operations was JPY 164.35 compared to JPY 163.68 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.64% | 3.62B | |
| -0.09% | 3.36B | |
| -23.44% | 3.06B | |
| +7.46% | 2.59B | |
| -9.26% | 1.75B | |
| +9.30% | 1.35B | |
| -20.60% | 957M | |
| -38.42% | 704M | |
| -0.53% | 450M | |
| -1.85% | 370M |
COSMOS PHARMACEUTICAL CORPORATION 
